Merck & Co. , Inc.
$150.33
▼ -$2.01 (-1.32%)Today
Open
$150.83
High
$152.22
Low
$150.09
Volume
4.3M
$77.5852-Week Range$156.92
Current: $150.33 · Near 52W High
MARKET CAP
$370.9B
P/E (TTM)
120.3x
P/B RATIO
8.9x
ROE
7.0%
EPS (TTM)▲ 5.1% Rev YoY
$1.25
DIVIDEND YIELD
2.23%
BETA
0.23
Defensive / low-beta
Company Info
Industry
Drug Manufacturers - General
Country
United States
Leadership
MR
Mr. Robert M. Davis J.D.
Chief Executive Officer
Stock Score
High Quality17/ 100
Val
10
Grw
13
Qly
32
Value 40%·Growth 35%·Quality 25%
Price History
$150.33▲ $66.24 (78.77%)
Overlays
Oscillators
Generating analysis...
01 / Income Statement
Income Statement
Revenue & Margin Trend
| Period | Revenue | OpEx | EBITDA | Net Income | EPS |
|---|---|---|---|---|---|
| 2022 | $59.28B | $23.59B | $21.32B | $14.52B | $5.71 |
| 2023 | $60.12B▲ | $41.03B | $6.91B | $0.36B▼ | $0.14 |
| 2024 | $64.17B▲ | $28.75B | $25.71B | $17.12B▲ | $6.74 |
| 2025 | $65.01B▲ | $26.52B | $28.26B | $18.25B▲ | $7.28 |
02 / Balance Sheet
Balance Sheet
Cash & Equivalents
$14.56B
Total Debt
$49.34B
Assets Distribution
Current Assets
Non-Current Assets
Liabilities & Equity
Current Liabilities
Non-Current Liabilities
Equity
03 / Cash Flow
Cash Flow
Positive free cash flow of $12.4B — 75% of operating cash flow.
Operating CF
$16.5B
Free Cash Flow
$12.4B
Investing CF
-$13.7B
Financing CF
-$1.9B
Cash Flow Mix
Operating Cash$16.5B
Investing Cash-$13.7B
Financing Cash-$1.9B
Net Change$809M
FCF Generation
The company converts 75% of operating cash flow into free cash flow, providing ample flexibility for capital allocation.
CapEx Burden
Capital expenditures consume $13.7B of operating cash. Monitor for maintenance vs. growth CapEx split.
Is the cash flow sustainable?
Positive Free Cash Flow
The company has flexibility for dividends, buybacks, debt reduction, or reinvestment in growth opportunities.
04 / Financial Ratios
Financial Ratios
Profitability
Gross Margin
74.8%
Gross Profit / Revenue
Operating Margin
34.0%
Op. Income / Revenue
Net Margin
28.1%
Net Income / Revenue
ROIC
17.9%
Return on Invested Capital
Liquidity & Leverage
Current Ratio
1.54x
Current Assets / Current Liab.
Cash Ratio
0.51x
Cash / Current Liab.
Debt-to-Equity
0.94
Total Debt / Equity
Asset Turnover
0.47
Revenue / Total Assets
Returns
ROE
7.0%
Return on Equity
ROA
11.9%
Return on Assets
EPS (TTM)
$1.25
Earnings Per Share
06 / Historical Trends
Historical Trends
Revenue
+3.1% CAGRNet Income
+7.9% CAGREPS
+8.4% CAGR05 / Dividends
Dividends & Yield
Dividend Yield
2.23%
Annual
Annual Dividend
$3.35
Per Share
Payout Ratio
268.2%
Div / EPS
Est. Div Growth
+2.0%
Approx. YoY
Dividend Safety Assessment
The payout ratio of 268% is elevated and may be at risk if earnings decline.
Recent Dividend Payments
| Date | Amount |
|---|---|
| 2026-06-15 | $0.85 |
| 2026-03-16 | $0.85 |
| 2025-12-15 | $0.85 |
| 2025-09-15 | $0.81 |
| 2025-06-16 | $0.81 |
| 2025-03-17 | $0.81 |
| 2024-12-16 | $0.81 |
| 2024-09-16 | $0.77 |
| 2024-06-17 | $0.77 |
| 2024-03-14 | $0.77 |
Institutional Ownership
Moderate Institutional Support
Top 3 institutional holders control 20.6% of shares, providing a stable foundation of institutional capital.
Retail Influence
Lower institutional concentration means retail sentiment and broader market trends may drive price action more noticeably.
Top Institutional Holders
Blackrock Inc.9.20%
227M shares
Vanguard Capital Management LLC6.54%
161.32M shares
State Street Corporation4.88%
120.41M shares
Wellington Management Group, LLP3.50%
86.25M shares
Vanguard Portfolio Management LLC2.75%
67.74M shares
Top ETFs Holding
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%
78.41M shares
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%
64M shares
iShares Trust-iShares Core S&P 500 ETF1.38%
33.97M shares
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.29%
31.94M shares
SCHWAB STRATEGIC TRUST-Schwab US Dividend Equity ETF1.25%
30.86M shares
07 / Market Events
Market Events
Upcoming Earnings
OCT
29THU
DateOct 29, 2026
DayThursday
Revenue Est.$17.3B
EPS Est.$2.21
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-06-03 | Forward | 1048:1000 |
| 1999-02-17 | Forward | 2:1 |
| 1992-05-26 | Forward | 3:1 |
| 1988-05-26 | Forward | 3:1 |
| 1986-05-27 | Forward | 2:1 |
08 / Market Intelligence
Market Intelligence
Analyst Consensus
Consensus (28 Ratings)
Buy
Strong Buy
5
Buy
15
Hold
8
Sell
0
Strong Sell
0
Recent Insider Trades
GUINDO CHIRFI
Officer
Sale
10,000 shs
DELUCA RICHARD ROBERT JR.
Officer
Sale
45,320 shs
ZACHARY JENNIFER L
General Counsel
Sale
80,315 shs
ZACHARY JENNIFER L
General Counsel
Sale
54,927 shs
Price Targets
Upside to Mean-0.6%
$105$150$186
Low
$105.00
Mean
$149.50
Median
$150.00
High
$186.00
Earnings History
Beat Rate
4/4
Avg Surprise
+18.5%
| Period | Est. EPS | Act. EPS | Surprise |
|---|---|---|---|
| 2025-09 | $2.35 | $2.58 | +9.9% |
| 2025-12 | $2.01 | $2.04 | +1.5% |
| 2026-03 | $-1.47 | $-1.28 | +13.1% |
| 2026-06 | $-0.26 | $-0.13 | +49.4% |